LYOPHILIZED PEPTIDE

CJC-1295 (no DAC) + Ipamorelin Blend

Co-lyophilized blend of CJC-1295 (no DAC) and Ipamorelin.

Format

Lyophilized blend, single-use vial

Availability

IN STOCK

FOR RESEARCH USE ONLY · NOT FOR HUMAN CONSUMPTION

Bundle

Total

$60

VIEW CART

STRUCTURAL DESCRIPTION

A 1:1 co-lyophilized blend of two well-characterised endocrine research peptides — modified GHRH (1-29) and the selective GHS-R1a agonist Ipamorelin — supplied as a single vial for paired-ligand studies.

MECHANISM IN RESEARCH CONTEXT

Combines GHRH-receptor and GHS-R1a engagement, a common pairing in pituitary somatotroph receptor-crosstalk research.

RELEVANT LITERATURE

Selected references

Provided for research context only. Inclusion does not imply any claim about the product or its use.

Synergistic effects of GHRH and GH-secretagogues in vitro
Bowers, Endocrine, 2001

More from this category

BPC-157

Synthetic pentadecapeptide fragment derived from a gastric protein sequence.

TB-500 (Thymosin β-4 Fragment)

Synthetic fragment of the naturally occurring Thymosin Beta-4 protein.

GHK-Cu

Naturally occurring copper-binding tripeptide (Glycyl-L-Histidyl-L-Lysine + Cu²⁺).